tradingkey.logo
tradingkey.logo
Search

Schwab (SCHA) vs. iShares (IJR): Which Small Cap ETF Should Investors Buy?

The Motley FoolJun 11, 2026 1:28 AM
facebooktwitterlinkedin
View all comments0

Key Points

  • Schwab U.S. Small-Cap ETF has a lower expense ratio of 0.04% compared to iShares Core S&P Small-Cap ETF's 0.06%.

  • While iShares Core S&P Small-Cap ETF holds 641 stocks, Schwab U.S. Small-Cap ETF provides broader exposure with 1,706 holdings.

  • Schwab U.S. Small-Cap ETF has delivered a higher 1-year total return of 36.30% but also experienced a deeper maximum drawdown.

Schwab U.S. Small-Cap ETF (NYSEMKT:SCHA) offers lower costs and broader diversification, while iShares Core S&P Small-Cap ETF (NYSEMKT:IJR) provides a more concentrated portfolio with slightly lower historical volatility.

Small-cap stocks can offer significant growth potential but often experience greater price swings than their large-cap counterparts. This comparison compares two popular low-cost options that track different small-cap indexes to help investors determine which best fits their risk profile and diversification needs.

Snapshot (cost & size)

MetricIJRSCHA
IssueriSharesSchwab
Expense ratio0.06%0.04%
1-yr return (as of June 10, 2026)30.3%36.2%
Dividend yield1.15%1.00%
Beta1.141.26
Assets under management (AUM)$103.6 billion$22.4 billion

Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The one-year return represents total return over the trailing 12 months. Dividend yield is the trailing 12-month distribution yield.

The Schwab fund is the more affordable option with an expense ratio of 0.04%, slightly lower than the 0.06% fee for the iShares fund. Regarding income, IJR offers a marginally higher payout of 1.15% compared to SCHA’s 1.00%.

Performance & risk comparison

MetricIJRSCHA
Max drawdown (5 yr)(28.00%)(30.80%)
Growth of $1,000 over five years (total return)$1,312$1,373

What's inside

The Schwab U.S. Small-Cap ETF (SCHA) was launched in 2009 and tracks a much broader set of 1,706 holdings. Its sector exposure tilts toward technology at 23.00%, financial services at 16.00%, and industrials at 16.00%. Its largest positions include Sandisk at 4.98%, Lumentum at 1.33%, and Revolution Medicines at 0.63%. Over the trailing 12 months, it paid $0.34 per share in dividends.

In contrast, the iShares Core S&P Small-Cap ETF (IJR) was launched in 2000 and follows a narrower index of 641 stocks. Its sector distribution is more balanced, with financial services, industrials, and technology each representing 16.00% of the fund. Its top holdings include Sanmina (0.79%), Viavi Solutions (0.75%), and Semtech (0.75%). Over the same trailing 12-month period, it paid $1.60 per share in dividends.

For more guidance on ETF investing, check out the full guide at this link.

Which ETF is the better buy?

Since late 2009, IJR and SCHA have delivered nearly identical annualized total returns of 12.6% and 12.3%, respectively. Not only are their total returns similar, but they both have uber-low expense ratios, comparable betas, and proximate dividend yields. However, there are a couple of reasons I might lean toward buying IJR over SCHA.

First, since IJR tracks an S&P Small Cap Index, the stocks it holds must meet a minimum level of profitability, whereas SCHA’s holdings do not. While the two ETFs’ returns have been largely similar over time, I just prefer the comfort of knowing IJR’s holdings are likely somewhat safer and more robust should we head into a recession or a similar pullback.

Second, since Sandisk has been a 39-bagger over just the last year, it has grown to become a somewhat uncomfortable 5% portion of SCHA’s holdings. While I’m all for letting stocks run as far as possible in my personal portfolio, that may not be the best approach for a small-cap ETF that’s supposed to be deeply diversified, and may not be suitable for certain investors.

Ultimately, I don’t think investors can go wrong with either of these ETFs, thanks to their low costs, steady returns, and exposure to a market niche most investors are probably chronically underinvested in. However, I’d lean ever-so-slightly to IJR for the two reasons mentioned.

Should you buy stock in Schwab Strategic Trust - Schwab U.s. Small-Cap ETF right now?

Before you buy stock in Schwab Strategic Trust - Schwab U.s. Small-Cap ETF, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Schwab Strategic Trust - Schwab U.s. Small-Cap ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $439,038!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,277,804!*

Now, it’s worth noting Stock Advisor’s total average return is 942% — a market-crushing outperformance compared to 206% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of June 10, 2026.

Josh Kohn-Lindquist has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Lumentum, Viavi Solutions, and iShares Core S&P Small-Cap ETF. The Motley Fool has a disclosure policy.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.